Nosopharm team identifies new class of antibiotics

Researchers at Nosopharm S.A.S. (Nimes, France) and academic colleagues identified a previously unknown class of naturally produced antibiotics that binds to a new site within the bacterial ribosome's decoding center and induces miscoding, killing the bacteria.

Previous studies have identified the Xenorhabdus genus -- a bacterial symbiont of the nematode worm that releases antibiotics against competing bacterial and fungal infections -- as a potential source of new antimicrobials...